Global Anti-Infective Ophthalmic Market Growth 2025-2031

Global Anti-Infective Ophthalmic Market Growth 2025-2031

The global Anti-Infective Ophthalmic market size is predicted to grow from US$ 1533 million in 2025 to US$ 1877 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.

LP Information, Inc. (LPI) ' newest research report, the “Anti-Infective Ophthalmic Industry Forecast” looks at past sales and reviews total world Anti-Infective Ophthalmic sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Infective Ophthalmic sales for 2025 through 2031. With Anti-Infective Ophthalmic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infective Ophthalmic industry.

This Insight Report provides a comprehensive analysis of the global Anti-Infective Ophthalmic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infective Ophthalmic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Infective Ophthalmic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infective Ophthalmic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infective Ophthalmic.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infective Ophthalmic market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Eyedrops
Gels
Ointments
Other

Segmentation by Application:
Hospital
Retail Pharmacy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-Infective Ophthalmic market?

What factors are driving Anti-Infective Ophthalmic market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-Infective Ophthalmic market opportunities vary by end market size?

How does Anti-Infective Ophthalmic break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.